Lab
Janeo LLC
Janeo LLC was paid $100K by Medicaid between Oct 2020 and Nov 2024, across 16 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 19% of everything it billed.
33Billing provider infoJANEO LLC
STUDIO CITY, CA 91604
STUDIO CITY, CA 91604
33aNPI1952758781assigned 05/23/2016
33bProvider typeClinical Medical Laboratory
28Total paid$100K
24GClaims16,073
24DCodes billed16
24AFirst – last monthOct 2020 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#325 of 561
Median peer was paid$222K
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 489 | $4K | |
| 2021 | 1,664 | $30K | |
| 2022 | 913 | $24K | |
| 2023 | 1,372 | $3K | |
| 2024incomplete | 11,635 | $39K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 19% | 574 | 442 | $19K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 17% | 298 | 205 | $17K |
| 91322 | 13% | 4,360 | 4,353 | $13K | |
| 90677 | 12% | 929 | 925 | $12K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 11% | 613 | 516 | $11K |
| 90653 | 7.7% | 2,549 | 2,534 | $8K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6.3% | 684 | 565 | $6K |
| 90480 | 4.1% | 2,849 | 2,842 | $4K | |
| 99401 | 3.7% | 927 | 716 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.3% | 55 | 42 | $3K |
| G0008 | Administration of influenza virus vaccine | 1.6% | 1,199 | 1,191 | $2K |
| 91320 | <1% | 297 | 294 | $720.54 |
4 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHERMAN, SHERRI (PRESIDENT/CEO/AO/PIC)